Is Iovance Biotherapeutics, Inc. (IOVA) a Buy, Sell, or Hold?
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$4.74 USD
$0.81 (20.61%)
- Volume
- 43.43M
- Average Volume
- 14.22M
- Market Capitalization
- $1.69B
- P/E Ratio
- -5.15
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $5.63
- Year Low
- $1.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-5.2% DOWNSIDE
$5.00 Price Target
UPSIDE/DOWNSIDE HIGH
-5.2% DOWNSIDE
$5.00 Price Target High
UPSIDE/DOWNSIDE LOW
137.0% UPSIDE
$2.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Andrea Newkirk | $2 | $2.44 | 2026-02-05 07:53 AM | -18.0% |
| UBS | David Dai | $2 | $1.66 | 2025-05-16 04:43 AM | 20.5% |
| Piper Sandler | Joseph Catanzaro | $7.5 | $5.85 | 2025-01-31 06:40 AM | 28.2% |
| UBS | David Dai | $17 | $9.82 | 2024-10-23 11:53 PM | 73.1% |
| Stifel Nicolaus | Benjamin Burnett | $23 | $3.97 | 2024-08-09 03:56 AM | 479.3% |
| Robert W. Baird | Colleen Kusy | $24 | $3.97 | 2024-08-09 02:35 AM | 504.5% |
| Piper Sandler | Joseph Catanzaro | $10 | $9.25 | 2024-07-28 10:11 PM | 8.1% |